| | Mortality due to any cause | Mortality due to lung cancer | | Relative risk (95% CI) | value | Relative risk (95% CI) | value |
| Stage III versus I/II | 1.66 (1.64, 1.68) | <0.001 | 2.11 (2.08, 2.15) | <0.001 | Stage IV versus I/II | 1.80 (1.78, 1.82) | <0.001 | 2.40 (2.36, 2.44) | <0.001 | Male versus female | 1.05 (1.04, 1.05) | <0.001 | 1.05 (1.04, 1.06) | <0.001 | Black versus white | 1.02 (1.01, 1.03) | <0.001 | 0.99 (0.98, 1.01) | 0.472 | Other versus white | 0.96 (0.94, 0.97) | <0.001 | 0.94 (0.92, 0.96) | <0.001 | Age 75–84 versus 65–74 | 1.04 (1.03, 1.05) | <0.001 | 1.02 (1.01, 1.03) | <0.001 | Age 85+ versus 65–74 | 1.07 (1.06, 1.08) | <0.001 | 1.02 (1.01, 1.03) | 0.008 | Metro versus Big Metro | 1.00 (1.00, 1.01) | 0.569 | 1.00 (0.99, 1.01) | 0.458 | Other versus Big Metro | 1.01 (1.00, 1.02) | 0.066 | 1.01 (1.00, 1.02) | 0.088 | Single versus Other | 1.00 (0.99, 1.01) | 0.079 | 0.99 (0.97, 1.01) | 0.076 | HIV versus non-HIV | 0.94 (0.86, 1.02) | 0.132 | 0.84 (0.73, 0.96) | 0.011 |
|
|